Nathan H. Walcker, MBA, chief executive officer, Florida Cancer Specialists & Research Institute (FCSRI), discusses what guests can expect at the in-person Tampa meeting of The American Journal of Managed Care®'s Institute for Value-Based Medicine® (IVBM), co-hosted by FCSRI.
In-person attendees of the upcoming Institute for Value-Based Medicine® (IVBM) meeting in Tampa, Florida, can expect rich dialogue regarding the state of oncology care today, including physician burnout, advancements in therapeutics, and more, said Nathan H. Walcker, MBA, chief executive officer, Florida Cancer Specialists & Research Institute.
Transcript
What should guests of the upcoming Tampa IVBM meeting look forward to?
First and foremost, I couldn't be more excited to be hosting the event and having a number of our clinical leaders and administrative leaders be participating. Ultimately, what folks can expect when it comes to that is a really rich dialogue around the state of oncology care today and recognizing that we've come a long way over the past 5 years; more specifically, through the COVID-19 pandemic.
Really unpacking a lot of the issues that we all know are out there, but doing so in 1 session, in 1 day. Hearing from folks on physician burnout, looking at great opportunities in clinical trials and advancements in therapeutics. And again, getting together with like-minded stakeholders that are making sure that at the end of the day, it would take a village to provide oncology care. And if we have an opportunity together to learn from one another, what better place to do it than in Tampa. Unfortunately, it's not football season, but there's enough sports to go around and the weather's not too bad either.
NSCLC Advancements Offer Hope, but Disparities Persist
February 20th 2025Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Abortion in 2025: Access, Fertility, and Infant Mortality Updates
February 20th 2025While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol in 2025, JAMA authors join the conversation with their published research and commentary.
Read More